Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.
Brain Res 2026 Jul 01; :150451. [Online ahead of print]

Abstract

Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine neurodegenerative disorder in which metabolic involvement may extend beyond proteotoxicity alone. We integrated cerebellar RNA sequencing with transcriptome-constrained genome-scale metabolic modeling to characterize metabolic dysregulation in transgenic SCA3 (84Q) versus control (15Q) mice and to relate cerebellar changes to circulating insulin-related measures. Differential expression and preranked gene set enrichment analyses revealed coordinated suppression of insulin/glucose-homeostasis modules and lipid/sterol programs in the SCA3 cerebellum. Context-specific metabolic models derived from iMM1865 and analyzed using parsimonious flux balance analysis, flux variability analysis, and flux sampling indicated reduced oxidative metabolism together with increased nucleotide salvage, one-carbon metabolism, and proteostasis-associated remodeling. Distribution-level comparisons of sampled fluxes detected widespread network reorganization despite modest median shifts. Plasma insulin was elevated in 84Q mice, whereas cerebellar Ins2 and Igf1 transcripts were reduced, consistent with an insulin-related dysregulation signature. Together, these data support broad metabolic reprogramming in the SCA3 cerebellum, including insulin/IGF-related alterations, and nominate pathway-level candidates for future mechanistic validation.

Authors+Show Affiliations

Pan SHVascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan. Electronic address: domingo80324@gmail.com.
Chang JCCenter of Regenerative Medicine and Tissue Repair, Institute of ATP, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan; General Research Laboratory of Research Department, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan.
Cheng WLVascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan.
Wei ACGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Room 410, BL Building, No. 1, Sec. 4, Roosevelt Rd., Da'an Dist., Taipei City 106319, Taiwan; Department of Electrical Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei City 10617, Taiwan.
Liu CSVascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan; Department of Neurology, Changhua Christian Hospital, No. 135, Nanhsiao St., Changhua City, Changhua County 50006, Taiwan; Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, No. 100, Sec. 1, Jingmao Rd., Beitun Dist., Taichung City 406040, Taiwan. Electronic address: liu48111@gmail.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

42386068